Select Medical (NYSE:SEM) Upgraded at Benchmark

Select Medical (NYSE:SEM - Get Free Report) was upgraded by investment analysts at Benchmark from a "hold" rating to a "buy" rating in a report released on Monday, Marketbeat.com reports. The brokerage currently has a $23.00 price target on the health services provider's stock. Benchmark's price target would indicate a potential upside of 24.48% from the stock's current price.

Several other research analysts have also recently commented on SEM. UBS Group reduced their target price on shares of Select Medical from $40.00 to $21.00 and set a "neutral" rating for the company in a report on Friday, January 3rd. Royal Bank of Canada lifted their price target on Select Medical from $40.00 to $47.00 and gave the stock an "outperform" rating in a report on Monday, November 4th. Finally, StockNews.com upgraded shares of Select Medical from a "hold" rating to a "buy" rating in a research note on Friday, February 21st. One analyst has rated the stock with a hold rating and four have given a buy rating to the company's stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $27.25.

Select Medical Trading Down 0.1 %

Shares of NYSE SEM traded down $0.02 during mid-day trading on Monday, hitting $18.48. The company's stock had a trading volume of 937,645 shares, compared to its average volume of 900,120. Select Medical has a one year low of $16.20 and a one year high of $40.98. The company's fifty day simple moving average is $19.07 and its 200-day simple moving average is $27.65. The company has a debt-to-equity ratio of 1.37, a current ratio of 1.13 and a quick ratio of 1.13. The stock has a market cap of $2.38 billion, a price-to-earnings ratio of 11.20, a price-to-earnings-growth ratio of 0.64 and a beta of 1.45.

Select Medical (NYSE:SEM - Get Free Report) last released its quarterly earnings data on Thursday, February 20th. The health services provider reported $0.18 EPS for the quarter, missing analysts' consensus estimates of $0.29 by ($0.11). Select Medical had a net margin of 3.23% and a return on equity of 14.04%. The company had revenue of $1.31 billion during the quarter, compared to the consensus estimate of $1.50 billion. On average, sell-side analysts anticipate that Select Medical will post 1.17 earnings per share for the current fiscal year.

Insider Activity

In related news, VP Robert G. Breighner, Jr. sold 4,989 shares of Select Medical stock in a transaction that occurred on Wednesday, December 4th. The stock was sold at an average price of $19.95, for a total transaction of $99,530.55. Following the transaction, the vice president now owns 30,356 shares of the company's stock, valued at $605,602.20. The trade was a 14.12 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 17.50% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Norges Bank bought a new position in shares of Select Medical in the fourth quarter worth $29,556,000. The Manufacturers Life Insurance Company raised its holdings in Select Medical by 2,552.7% in the 4th quarter. The Manufacturers Life Insurance Company now owns 1,596,414 shares of the health services provider's stock worth $30,092,000 after purchasing an additional 1,536,234 shares in the last quarter. Hood River Capital Management LLC grew its holdings in shares of Select Medical by 404.8% during the 4th quarter. Hood River Capital Management LLC now owns 1,755,733 shares of the health services provider's stock worth $33,096,000 after acquiring an additional 1,407,902 shares during the period. Point72 Asset Management L.P. increased its stake in shares of Select Medical by 144.2% in the 3rd quarter. Point72 Asset Management L.P. now owns 2,059,791 shares of the health services provider's stock worth $71,825,000 after acquiring an additional 1,216,263 shares in the last quarter. Finally, Invesco Ltd. lifted its holdings in shares of Select Medical by 48.6% during the fourth quarter. Invesco Ltd. now owns 2,643,943 shares of the health services provider's stock valued at $49,838,000 after purchasing an additional 864,852 shares during the last quarter. 89.48% of the stock is currently owned by hedge funds and other institutional investors.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.